Krystal Biotech
Today, February 26, 2024, Krystal Biotech (KRYS) firm announces its full year financial results and business updates.  Read this press release to learn about the company.

• New England Journal of Medicine publication of the use of B-VEC eyedrop formulation.
• Reached alignment with FDA to enable approval of B-VEC eyedrop formulation . . .
  
  This content is for paid subscribers.
  Please click here to subscribe or here to log in.
  Today’s Highlights

  Krystal Biotech (KRYS)

  February 26, 2024
  Tweet Pin It